TY - JOUR
T1 - De novo congestive heart failure after kidney transplantation
T2 - A common condition with poor prognostic implications
AU - Lentine, Krista L.
AU - Schnitzler, Mark A.
AU - Abbott, Kevin C.
AU - Li, Leiming
AU - Burroughs, Thomas E.
AU - Irish, William
AU - Brennan, Daniel C.
N1 - Funding Information:
Supported in part by the 2004 Clinical Scientist in Nephrology Award from the American Kidney Fund (K.L.L.); National Institutes of Health Loan Repayment Award for Clinical Research (K.L.L.); grants no. K25-DK-02916-01 (M.A.S.) and K24DK002886-02 (D.C.B.) from the National Institute of Diabetes and Digestive and Kidney Diseases; and additional funding from Novartis (K.L.L., M.A.S.).
PY - 2005/10
Y1 - 2005/10
N2 - •Background: We aim to describe the risk, predictors, and outcomes associated with de novo congestive heart failure (CHF) after kidney transplantation. Methods: We used registry data from the US Renal Data System to retrospectively investigate de novo CHF in adult Medicare-insured transplant recipients and wait-listed candidates in 1995 to 2001. Heart failure was ascertained from inpatient and outpatient billing records, and participants were followed up until loss of Medicare or December 31, 2001. We used extended Cox hazards analysis to identify independent correlates of posttransplantation de novo CHF (adjusted hazard ratio [AHR], 95% confidence interval [CI]) and examine de novo CHF as a predictor of death and graft loss after transplantation. Results: In 27,011 transplant recipients, cumulative incidences of de novo CHF were 10.2% (95% CI, 9.8 to 10.6) and 18.3% (95% CI, 17.8 to 18.9) at 12 and 36 months and decreased to less than the demographic-adjusted incidence on the waiting list beyond the early posttransplantation period. Risk factors for de novo CHF included older recipient age, female sex, unemployed status at transplantation, pretransplantation comorbidities (anemia, diabetes mellitus, myocardial infarction, angina, cardiac arrhythmia, and peripheral vascular disease), transplant from older donors, donor cardiovascular death, and delayed graft function. We identified pretransplantation obesity, smoking, and posttransplantation complications, including hypertension, anemia, new-onset diabetes, myocardial infarction, and graft failure, as potentially modifiable correlates of de novo CHF. In separate analyses, de novo CHF predicted death (AHR, 2.6; 95% CI, 2.4 to 2.9) and death-censored graft failure (AHR, 2.7; 95% CI, 2.4 to 3.0). Conclusion: Although associations may not reflect causality, identification of potentially mutable de novo CHF risk factors suggests targets for improving outcomes that should be evaluated prospectively.
AB - •Background: We aim to describe the risk, predictors, and outcomes associated with de novo congestive heart failure (CHF) after kidney transplantation. Methods: We used registry data from the US Renal Data System to retrospectively investigate de novo CHF in adult Medicare-insured transplant recipients and wait-listed candidates in 1995 to 2001. Heart failure was ascertained from inpatient and outpatient billing records, and participants were followed up until loss of Medicare or December 31, 2001. We used extended Cox hazards analysis to identify independent correlates of posttransplantation de novo CHF (adjusted hazard ratio [AHR], 95% confidence interval [CI]) and examine de novo CHF as a predictor of death and graft loss after transplantation. Results: In 27,011 transplant recipients, cumulative incidences of de novo CHF were 10.2% (95% CI, 9.8 to 10.6) and 18.3% (95% CI, 17.8 to 18.9) at 12 and 36 months and decreased to less than the demographic-adjusted incidence on the waiting list beyond the early posttransplantation period. Risk factors for de novo CHF included older recipient age, female sex, unemployed status at transplantation, pretransplantation comorbidities (anemia, diabetes mellitus, myocardial infarction, angina, cardiac arrhythmia, and peripheral vascular disease), transplant from older donors, donor cardiovascular death, and delayed graft function. We identified pretransplantation obesity, smoking, and posttransplantation complications, including hypertension, anemia, new-onset diabetes, myocardial infarction, and graft failure, as potentially modifiable correlates of de novo CHF. In separate analyses, de novo CHF predicted death (AHR, 2.6; 95% CI, 2.4 to 2.9) and death-censored graft failure (AHR, 2.7; 95% CI, 2.4 to 3.0). Conclusion: Although associations may not reflect causality, identification of potentially mutable de novo CHF risk factors suggests targets for improving outcomes that should be evaluated prospectively.
KW - Heart failure
KW - Kidney transplantation
KW - Medicare
KW - Registry
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=25644445400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=25644445400&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2005.06.019
DO - 10.1053/j.ajkd.2005.06.019
M3 - Article
C2 - 16183428
AN - SCOPUS:25644445400
SN - 0272-6386
VL - 46
SP - 720
EP - 733
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -